Biochemical changes associated with benign prostatic hyperplasia (bph) in ageing men attending clinic at university of nigeria teaching hospital (unth), ituku-ozalla, enugu state of nigeria
Table Of Contents
Chapter ONE
INTRODUCTION
- 1.1Introduction
- 1.2Background of Study
- 1.3Problem Statement
- 1.4Objective of Study
- 1.5Limitation of Study
- 1.6Scope of Study
- 1.7Significance of Study
- 1.8Structure of the Research
- 1.9Definition of Terms
Chapter TWO
LITERATURE REVIEW
- 2.1Overview of Benign Prostatic Hyperplasia (BPH)
- 2.2Risk Factors Associated with BPH
- 2.3Pathophysiology of BPH
- 2.4Symptoms and Diagnosis of BPH
- 2.5Treatment Options for BPH
- 2.6Complications of Untreated BPH
- 2.7Impact of BPH on Quality of Life
- 2.8Relationship Between Ageing and BPH
- 2.9Research on Biochemical Changes in BPH
- 2.10Current Trends in Managing BPH
Chapter THREE
RESEARCH METHODOLOGY
- 3.1Research Design and Methodology
- 3.2Selection of Study Participants
- 3.3Data Collection Procedures
- 3.4Biochemical Analysis Methods
- 3.5Statistical Analysis Techniques
- 3.6Ethical Considerations
- 3.7Research Limitations
- 3.8Data Validation Methods
Chapter FOUR
DATA PRESENTATION AND ANALYSIS
- 4.1Overview of Research Findings
- 4.2Analysis of Biochemical Changes in BPH
- 4.3Comparison with Normal Prostate Function
- 4.4Correlation Between Ageing and Biochemical Markers
- 4.5Impact of Treatment on Biochemical Parameters
- 4.6Discussion on Clinical Implications
- 4.7Recommendations for Further Research
- 4.8Practical Applications of Findings
Chapter FIVE
SUMMARY, CONCLUSION AND RECOMMENDATIONS
- 5.1Summary of Research Findings
- 5.2Conclusion
- 5.3Implications for Clinical Practice
- 5.4Contribution to Existing Knowledge
- 5.5Recommendations for Healthcare Providers
Project Abstract
<p> </p><div><p>This study was aimed at investigating biochemical changes associated with benign prostatic hyperplasia in ageing men attending clinic at the university of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu State, Nigeria. The assessment included 50 men with BPH attending clinic in addition to 50 healthy men (control). All samples were divided into 5 groups and with varying age ranges (Group 1 Normal control, Group 2 BPH patients ≤ 60 years, on treatment, Group 3 BPH patients ≤ 60 years, not on treatment, Group 4 BPH patients ≥ 60 years, taking treatment, Group 5 BPH patients ≥ 60 years, not on treatment).PSA levels of BPH positive subjects under treatment increased significantly (p < 0.05) compared with the control. There was a significantly (p < 0.05) high level of calcium in subjects who were ≤60 years of age that are on treatment compared with group 1 (control). Also, the level of blood urea nitrogen (BUN) recorded a high significance (p < 0.05) in comparison to the normal control. In the same study, zinc level decreased non-significantly (p > 0.05) in the groups under investigation and the level of sodium in the blood of positive treated and untreated BPH patients was non-significantly (p > 0.05) high when compared to the healthy subjects. Iron level showed a non-significant (p > 0.05) elevation in subjects ≤ 60 years of age who were on treatment and a significantly level (p < 0.05) in the other groups under investigation. Furthermore, there was a significant (p<0.05) elevation in the level of potassium ion concentration of BPH patients of group 2 and 5 as was also observed in the levels of magnesium group 2 and 4; though, the level of magnesium dropped significantly in BPH untreated group (group 3 and 5). The result of this study also showed a non-significantly (p > 0.05) higher level of selenium in BPH positive patients of all the groups under investigation compared with group 1 (normal control) while creatinine levels showed a significant (p< 0.05) elevation in all the groups being investigated when compared with group 1.</p><p></p></div><h3></h3><br> <br><p></p>
Project Overview